Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy
| Autor: | Akira Hirata, Mikiko Fukushima, Takahiro Kawaji, Nanako Awai, Akiomi Takano, Yasuya Inomata, Hidenobu Tanihara |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
medicine.medical_specialty Triamcinolone acetonide Visual acuity genetic structures medicine.medical_treatment Eye disease Visual Acuity Vitrectomy Triamcinolone Acetonide Macular Edema Injections Central retinal vein occlusion Retinal Vein Occlusion medicine Humans Prospective Studies Macular edema Glucocorticoids Aged Aged 80 and over business.industry Middle Aged medicine.disease eye diseases Surgery Ophthalmology Treatment Outcome Connective Tissue Branch retinal vein occlusion Female sense organs medicine.symptom Safety business Orbit medicine.drug Retinopathy |
| Zdroj: | American journal of ophthalmology. 140(3) |
| ISSN: | 0002-9394 |
| Popis: | Purpose To evaluate the effectiveness and safety of trans-Tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion (BRVO) after vitrectomy. Design Prospective interventional case series. Methods The study included 20 eyes of 20 patients with BRVO, characterized by macular edema lasting more than 3 months after vitrectomy. Trans-Tenon retrobulbar injection of 40 mg triamcinolone was performed, and visual and anatomic responses were evaluated. Results Mean foveal thickness was 499.4 ± 209.1 μm preoperatively, 281.8 ± 110.1 μm at 2-week follow-up, and 196.9 ± 92.1 μm at 6-month follow-up ( P t test). Improvement of visual acuity by at least 0.2 logMAR (logarithm of the minimum angle of resolution) was seen in 14 (70%) of the 20 eyes. Conclusions Trans-Tenon retrobulbar injection of triamcinolone may be an alternative for additional treatment of eyes with BRVO that remains after vitrectomy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect